- Home
- LGND vs BLKB Comparison
LGND vs BLKB Comparison
Compare LGND & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- BLKB
- Stock Information
- Founded
- LGND 1987
- BLKB 1981
- Country
- LGND United States
- BLKB United States
- Employees
- LGND 68
- BLKB N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- BLKB Computer Software: Prepackaged Software
- Sector
- LGND Health Care
- BLKB Technology
- Exchange
- LGND Nasdaq
- BLKB Nasdaq
- Market Cap
- LGND 3.2B
- BLKB 3.2B
- IPO Year
- LGND 1992
- BLKB 2004
- Fundamental
- Price
- LGND $184.44
- BLKB $67.62
- Analyst Decision
- LGND Strong Buy
- BLKB Hold
- Analyst Count
- LGND 8
- BLKB 2
- Target Price
- LGND $144.71
- BLKB $70.50
- AVG Volume (30 Days)
- LGND 139.7K
- BLKB 233.7K
- Earning Date
- LGND 08-05-2025
- BLKB 10-29-2025
- Dividend Yield
- LGND N/A
- BLKB N/A
- EPS Growth
- LGND N/A
- BLKB N/A
- EPS
- LGND N/A
- BLKB N/A
- Revenue
- LGND $181,488,000.00
- BLKB $1,136,093,000.00
- Revenue This Year
- LGND $18.41
- BLKB N/A
- Revenue Next Year
- LGND $18.87
- BLKB $4.18
- P/E Ratio
- LGND N/A
- BLKB N/A
- Revenue Growth
- LGND 53.40
- BLKB N/A
- 52 Week Low
- LGND $81.74
- BLKB $58.05
- 52 Week High
- LGND $129.90
- BLKB $88.95
- Technical
- Relative Strength Index (RSI)
- LGND 58.00
- BLKB 63.06
- Support Level
- LGND $182.87
- BLKB $63.84
- Resistance Level
- LGND $194.44
- BLKB $70.71
- Average True Range (ATR)
- LGND 5.35
- BLKB 1.59
- MACD
- LGND -0.77
- BLKB 0.48
- Stochastic Oscillator
- LGND 40.05
- BLKB 64.36
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.